02616.HK
CStone Pharmaceuticals
HKSE · Healthcare · Biotechnology · CN
HKD 5.34
−0.84%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- 1.91x
- P/E 2028E
- 27.91x
- P/S forward
- 9.93x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 4.90x
- Price / sales
- 15.00x
- Price / cash flow
- -113.05x
Enterprise value
- Enterprise value
- HKD 6.0B
- EV / sales
- 12.15x
- EV / EBITDA
- -14.94x
- EV / EBIT
- -13.23x
- Market cap
- HKD 7.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026